Lipid nanoparticles for nucleic acid delivery: Current perspectives

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Nanomedicine and Drug Delivery Systems

Background:

• Nucleic Acid (NA) therapeutics offer significant potential to revolutionize medicine.
• Effective and safe delivery of NA therapies to target cells remains a critical challenge.
• Lipid Nanoparticles (LNP) have emerged as a leading delivery vector for NA drugs.

Purpose of the Study:

• To provide a comprehensive review of the current state-of-the-art in Lipid Nanoparticle (LNP) technology.
• To discuss advancements in LNP design and development for therapeutic applications.
• To explore the clinical status and future prospects of LNP-based NA delivery.

Main Methods:

• Comprehensive literature review of Lipid Nanoparticle (LNP) technology.
• Analysis of key advances in LNP design, formulation, and characterization.
• Evaluation of LNP applications in various therapeutic areas and clinical trials.

Main Results:

• Lipid Nanoparticles (LNP) are the most advanced vector for Nucleic Acid (NA) drug delivery, with successful clinical approvals.
• Significant progress has been made in LNP design, enabling a broad spectrum of therapeutic applications.
• LNP technology is progressing through clinical trials, demonstrating promising future potential.

Conclusions:

• Lipid Nanoparticles (LNP) are a pivotal technology for enabling the clinical translation of Nucleic Acid (NA) therapeutics.
• Continued innovation in LNP design and development will expand their therapeutic utility.
• LNP technology holds substantial promise for the future of targeted NA drug delivery and treatment.